Kerriamycin B inhibits protein SUMOylation

Journal of Antibiotics

Volumn 62, Issue 4, 2009, Pages 221-224

  Fukuda, Isao ^a,b   Ito, Akihiro ^a,b,c   Uramoto, Masakazu ^a   Saitoh, Hisato ^d   Kawasaki, Hisashi ^e   Osada, Hiroyuki ^a,b   Yoshida, Minoru ^a,b,c  

^a RIKEN   (Japan)

^b SAITAMA UNIVERSITY   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^d KUMAMOTO UNIVERSITY   (Japan)

^e TOKYO DENKI UNIVERSITY   (Japan)

Author keywords

Kerriamycin B; SUMO 1; SUMO activating enzyme (E1)

Indexed keywords

KERRIAMYCIN B; POLYPEPTIDE ANTIBIOTIC AGENT; SUMO 1 PROTEIN; THIOESTER; UNCLASSIFIED DRUG;

ACTINOBACTERIA; ANTIBACTERIAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; BACTERIAL STRAIN; CARCINOGENESIS; CATALYSIS; CONJUGATION; DRUG ACTIVITY; DRUG TARGETING; ENZYME ACTIVITY; PRIORITY JOURNAL; PROTEIN ISOLATION; PROTEIN LOCALIZATION; PROTEIN PURIFICATION; PROTEIN STABILITY; PROTEIN STRUCTURE; REGULATORY MECHANISM; STRUCTURE ACTIVITY RELATION; SUMOYLATION;

ANTHRAQUINONES; ANTIBIOTICS, ANTINEOPLASTIC; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; MAGNETIC RESONANCE SPECTROSCOPY; PROTEIN PROCESSING, POST-TRANSLATIONAL; SMALL UBIQUITIN-RELATED MODIFIER PROTEINS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 67249125841     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.1038/ja.2009.10     Document Type: Article

References (16)

1. Johnson, E. S. Protein modification by SUMO. Annu. Rev. Biochem. 73, 355-382 (2004).
2. Hay, R. T. SUMO: a history of modification. Mol. Cell 18, 1-12 (2005).
3. Verger, A., Perdomo, J. & Crossley, M. Modification with SUMO. A role in transcriptional regulation. EMBO Rep. 4, 137-142 (2003).
4. Dorval, V. & Fraser, P. E SUMO on the road to neurodegeneration. Biochim. Biophys. Acta 1773, 694-706 (2007).
5. Boggio, R. & Chiocca, S. Viruses and sumoylation: recent highlights. Curr. Opin. Microbiol. 9, 430-436 (2006).
6. Alarcon-Vargas, D. & Ronai, Z. SUMO in cancer-wrestlers wanted. Cancer Biol. Ther 1, 237-242 (2002).
7. Moschos, S. J. & Mo, Y. Y. Role of SUMO/Ubc9 in DNA damage repair and tumorigenesis. J. Mol. Histol. 37, 309-319 (2006).
8. Uchimura, Y., Nakao, M. & Saitoh, H. Generation of SUMO-1 modified proteins in E. coli: towards understanding the biochemistry/structural biology of the SUMO-1 pathway. FEBS Lett. 564, 85-90 (2004).
9. Saitoh,N.et al In situ SUM Oylation analysis reveals a modulatory role of RanBP2 in the nuclear rim and PML bodies. Exp. Cell Res. 312, 1418-1430 (2006).
10. Hayakawa, Y. et al Kerriamycins A B and C, New Isotetracenone Antibiotics. Agric. Biol. Chem. 51, 1397-1405 (1987).
11. Bossis, G. & Melchior, F. Regulation of SUM Oylation by reversible oxidation of SUMO conjugating enzymes. Mol. Cell 21, 349-357 (2006).
12. Fukuda, I. et al Ginkgolic acid inhibits protein SUM Oylation by blocking formation of the E1-SUMO intermediate. Chem. Biol. (in press).
13. Mo, Y. Y. & Moschos, S. J. Targeting Ubc9 for cancer therapy. Expert. Opin. Ther. Targets 9, 1203-1216 (2005).
14. Mo, Y. Y. et al A role for Ubc9 in tumorigenesis. Oncogene 24, 2677-2683 (2005).
15. Doniels-Silvers, A. L., Nimri, C. F., Stoner, G. D., Lubet, R. A. & You, M. Differential gene expression in human lung adenocarcinomas and squamous cell carcinomas. Clin. Cancer Res. 8, 1127-1138 (2002).
16. Kim, J. H. et al Roles of sumoylation of a reptin chromatin-remodelling complex in cancer metastasis. Nat. Cell Biol. 8, 631-639 (2006).